Delivery Order SPE2DB22D1106-SPE2DB25FEZU6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on July 31, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a contract ceiling value of $2,852.62. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.23 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,895.50 to AmerisourceBergen Drug Corp for the supply of Nexium DR 20 mg capsules (30-count units). The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $8,400.65 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is performing the work at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nexium DR 40 mg capsules (30-count units) valued at $3,942.12, with a firm fixed price and no set-aside designation. The order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a $3,543.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nexium DR 40 mg capsules (90-count units). This non-set-aside delivery order, which represents a child contract under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. The contract supports the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) under a firm fixed-price contract valued at $2,265.27. The order was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a contract ceiling value of $2,250.08 and a firm fixed price structure. This non-set-aside competitive award is scheduled for completion by August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZU6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nexium DR 40 mg capsules (30-count packages) with a ceiling value of $2,250.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution center. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's contract portfolio with DLA demonstrates its capability to fulfill varied pharmaceutical needs across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/25/25 |